Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| AK1-H5283 | Human | Human Akt1 Protein, His,Strep II Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Capivasertib | AZD-5363 | Approved | Astex Pharmaceuticals Inc, Cancer Research Technology, The Institute Of Cancer Research, London | Truqap | United States | Breast Neoplasms | Astrazeneca Pharmaceuticals Lp | 2023-11-16 | Uterine Neoplasms; Multiple Myeloma; Breast Neoplasms; Prostatic Neoplasms; Hormone-Sensitive Prostate Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Glioma; Metastatic breast cancer; Urinary Bladder Neoplasms; Lymphoma; Lung Neoplasms; Thyroid Neoplasms; HR-positive breast cancer; Fallopian Tube Neoplasms; Lymphoma, Non-Hodgkin; Uterine Cervical Neoplasms; Melanoma; Esophageal Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Skin Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Colonic Neoplasms; Prostatic Neoplasms, Castration-Resistant | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Afuresertib | GSK-21110183; GSK-2110183B; GSK-2110183C; LAE002; ASB-183; GSK-2110183; LAE-002 | Phase 3 Clinical | Novartis Pharma Ag, Glaxosmithkline Plc | Breast Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Histiocytosis, Langerhans-Cell; Hematologic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Triple Negative Breast Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Solid tumours; Ovarian Neoplasms | Details |
| Ipatasertib | RG-7440; GCD-0068; GDC-0068; RO-5532961 | Phase 3 Clinical | Array Biopharma, Genentech Inc | Lymphoma, Non-Hodgkin; Hepatic Insufficiency; Neoplasms, Unknown Primary; Laryngeal Neoplasms; Paranasal Sinus Diseases; Endometrial Neoplasms; Carcinoma, Squamous Cell; Metastatic breast cancer; Paranasal Sinus Neoplasms; Mouth Neoplasms; Genital Neoplasms, Female; Fallopian Tube Neoplasms; Urogenital Neoplasms; Lymphoma; Lip Neoplasms; Carcinoma, Endometrioid; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Hypopharyngeal Neoplasms; Solid tumours; Head and Neck Neoplasms; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Neoplasm, Residual; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Breast Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Oropharyngeal Neoplasms; Peritoneal Neoplasms | Details |
| SR-0379 | SR-0379 | Phase 3 Clinical | FunPep Co Ltd | Skin Ulcer | Details |
| Triciribine Phosphate | NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 | Phase 2 Clinical | National Cancer Institute | Hematologic Neoplasms; Leukemia; Ovarian Neoplasms; Neoplasms; Breast Neoplasms | Details |
| Miransertib | MK-7075; ARQ-092 | Phase 2 Clinical | Arqule Inc | Ovarian Neoplasms; Solid tumours; Proteus Infections; Neoplasms; PIK3CA-Related Overgrowth Spectrum; Lymphoma; Endometrial Neoplasms; Proteus Syndrome | Details |
| Iopofosine I-131 | CLR-131; NM404; (131)I-CLR1404; 131I-NM-404; HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404 | Phase 2 Clinical | University Of Michigan | Neuroblastoma; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Glioma; Lymphoma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Brain Neoplasms; Osteosarcoma; Lymphoma, B-Cell, Marginal Zone; Sarcoma, Ewing; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Head and Neck Neoplasms; Solid tumours; Rhabdomyosarcoma | Details |
| Ursolic Acid | NSC-167406; NSC-4060 | Phase 2 Clinical | University Of Guadalajara | Prostatic Neoplasms; Carcinoma, Hepatocellular; Sarcopenia; Lung Neoplasms; Muscular Atrophy; Colorectal Neoplasms; Quadriplegia; Cholangitis, Sclerosing; Breast Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Insulin Resistance; Metabolic Syndrome; Paraplegia; Spinal Cord Injuries; Stomach Neoplasms | Details |
| Uprosertib/Trametinib Dimethyl Sulfoxide | Phase 2 Clinical | Novartis Pharma Ag | Endometrial Neoplasms; Leukemia, Myeloid, Acute; Uterine Cervical Neoplasms | Details | |
| Selumetinib sulfate/MK-2206 | Phase 2 Clinical | Astrazeneca Plc, Merck & Co Inc | Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung | Details | |
| Uprosertib | GSK-795; GSK-2141795; GSK-2141795C; UPB-795 | Phase 2 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute | Solid tumours; Hematologic Neoplasms; Skin Melanoma; Neoplasms; Triple Negative Breast Neoplasms; Uveal melanoma; Multiple Myeloma; Adenocarcinoma, Clear Cell; Breast Neoplasms; Endometrial Neoplasms; Uterine Neoplasms; Lymphoma; Leukemia, Myeloid, Acute; Melanoma; Uterine Cervical Neoplasms | Details |
| RX-0301 | WGI-0301; RX-0201改良型; HC0301; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N; RX-0301 | Phase 2 Clinical | Rexahn Pharmaceuticals Inc | Liver Neoplasms; Solid tumours; Carcinoma, Hepatocellular | Details |
| MK-2206 | MK2206; MK-2206; BIND-2206; NSC-749607 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Colorectal Neoplasms; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Intraocular Lymphoma; Lymphoma; Lymphoma, Large-Cell, Anaplastic; Glioma; Leukemia, Myelomonocytic, Juvenile; Lymphoma, T-Cell, Cutaneous; Neoplasms, Gonadal Tissue; Lung Neoplasms; Carcinoma, Squamous Cell; Leukemia, Myeloid, Acute; Lymphoproliferative Disorders; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Peritoneal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Sezary Syndrome; Bile Duct Neoplasms; Prostatic Neoplasms; Lymphoma, Follicular; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Adenocarcinoma; Leukemia, T-Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Leukemia, Prolymphocytic; Breast Neoplasms, Male; Mycosis Fungoides; Carcinoma, Hepatocellular; Central Nervous System Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Cholangiocarcinoma; Angioimmunoblastic T-cell Lymphoma; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Thymoma; Gallbladder Neop | Details |
| NTQ-1062 | NTQ-1062; NTQ1062 | Phase 2 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Solid tumours; Breast Neoplasms; HR-positive breast cancer | Details |
| HZB-0071 | HZB-0071 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd | Neoplasms | Details |
| Rupitasertib | DIACC3010; M-2698; MSC-2363318A; DIACC-3010 | Phase 1 Clinical | Emd Serono Inc | Solid tumours; Stomach Neoplasms; Glioblastoma; Breast Neoplasms | Details |
| Honokiol | HU-002; JRF-101 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung | Details |
| CMX-2043 | LIP-EA; CMX-2043; R-LIP-EA-OH | Phase 1 Clinical | Ischemix Llc | Brain Injuries, Traumatic; Angina, Unstable; Coronary Artery Disease; Cardiovascular Diseases; Non-ST Elevated Myocardial Infarction | Details |
| ALTA-2618 | ALTA-2618 | Phase 1 Clinical | Alterome Therapeutics Inc | Solid tumours; Neoplasms; Breast Neoplasms; Endometrial Neoplasms; Neoplasm Metastasis | Details |
| Hu-7691 | Hu-7691 | Phase 1 Clinical | Zhejiang University | Solid tumours; Neoplasms | Details |
| Oxysterols (Intsel Chimos) | Clinical | Centre National De La Recherche Scientifique (Cnrs) | Glioma | Details |
This web search service is supported by Google Inc.
A-Z
